Explore federal awards
Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
Export these results to CSV · 10 matching records
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMSDepartment of Health and Human Services$0 obligationsEnds Aug 31, 2022
COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)Department of Health and Human Services$26.1M obligationsEnds Aug 14, 2027
REGULATORY MANAGEMENT CENTER (RMC)Department of Health and Human Services$17.4M obligationsEnds Oct 31, 2026
FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASUREDepartment of Health and Human Services$724.5K obligationsEnds Jul 15, 2027
NIAID CLINICAL SITE MONITORING (NCSM)Department of Health and Human Services$73.2M obligationsEnds Jan 31, 2027
DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)Department of Health and Human Services$3.1M obligationsEnds Dec 14, 2026
BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC…Department of Health and Human Services$117.4M obligationsEnds Sep 30, 2030
COVID 19. THIS TASK ORDER IS TO PROVIDE COMPREHENSIVE/FULL CLINICAL TRIAL MANAGEMENT SUPPORT SERVICES TO THE ONGOING ACTIV-2 CLINICAL TRIAL. THE CONTRACTOR SHALL COMPLY WITH…Department of Health and Human Services$34.6M obligationsEnds Nov 5, 2022
"COVID 19"COMPLETION OF ACTIV 2 STUDYDepartment of Health and Human Services$64.0M obligationsEnds Aug 31, 2025
THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE)Department of Health and Human Services$2.3M obligationsEnds Mar 22, 2024